新艾滋疫苗可适应不断变异病毒:明年临床试验


新艾滋疫苗可适应不断变异病毒:明年临床试验

 
 
 
 
 

新艾滋疫苗可适应不断变异病毒:明年临床试验

http://www.sina.com.cn  2011年04月03日 09:20  新浪科技
这个实验室电子扫描图显示的是白细胞壁上的免疫缺陷病毒(HIV-1)芽接(绿色) 这个实验室电子扫描图显示的是白细胞壁上的免疫缺陷病毒(HIV-1)芽接(绿色)
贝特·科伯的两位好友因艾滋病去世后,她献出毕生时间研究艾滋病毒疫苗 贝特·科伯的两位好友因艾滋病去世后,她献出毕生时间研究艾滋病毒疫苗

  新浪科技讯 北京时间4月3日消息,据国外媒体报道,科学家表示,一种可以骗过致命艾滋病毒的疫苗,可能会在明年进行人类临床试验。一个国际科研组设计的这种“镶嵌疫苗”能够适应不断变异的艾滋病毒。

  艾滋病毒能够迅速变异,这使当前的药物对它毫无办法。美国新墨西哥州洛斯阿拉莫斯国家实验室的贝特·科伯是该科研组的一名成员,她已经在这个项目工作20多年。她说:“研究艾滋病毒就如同踏上了一条进化快车道。要是你只用一种药物,艾滋病毒能通过进化轻松避开它。这也是治疗这种疾病同时要用3或4种药物的原因。”

  艾滋病毒主要由蛋白质组成,它能引发艾滋病,破坏人体免疫系统,导致患者极易感染疾病和患上肿瘤。2009年,这种疾病导致全球180万人丧生。传统艾滋病毒疫苗通过刺激人体免疫系统,让它能够识别出艾滋病毒里的特殊氨基酸。而镶嵌疫苗由很多通过电脑排序的人造蛋白质组成。它们会暗示人体免疫系统,令其对多种艾滋病毒变种产生反应。洛斯阿拉莫斯国家实验室的科伯及其同事利用自己制作的一个巨大的数据库,把这些蛋白质拼接在一起,这个数据库包含几十万个艾滋病毒片段的信息。

  这种镶嵌疫苗将打破25年来的尴尬僵局,找到治疗艾滋病的办法。每天有7500人感染艾滋病,每年有200万人死于艾滋病。以前的所有艾滋病毒疫苗临床试验均以失败而告终。根据早期电脑模拟结果预测,镶嵌疫苗会比天然艾滋病毒基因表现更出色。去年这一说法部分得到证实,当时发表在《自然医学》上的研究成果显示,镶嵌疫苗促使老鼠和猴子产生很强的免疫响应。一个国际科研组现在希望2012年对镶嵌疫苗进行人类临床试验,该研究由比尔及梅琳达·盖茨基金会和美国国家卫生研究院资助。

  科伯博士已经有几位朋友死于艾滋病,她表示,她迫切希望这种新方法能取得成功。“我用毕生时间研发这种疫苗。此刻根据动物实验结果,我深信这是一种好方法,是有益的人类试验。”如果早期阶段的安全试验显示人类使用这种疫苗很安全,科学家将会进行第二阶段的试验,在更多人身上测试这种药物,评估它的效果。据估计,有7.3万名英国人是艾滋病毒携带者,其中2.1万人并不知道自己体内含有这种病毒。(孝文)

艾滋病不治会早死,早治才康复 艾滋病不治会早死,早治才康复 艾滋病不治会早死,早治才康复 艾滋病不治会早死,早治才康复

 
图示∶2010年12月即将出版的《中国特色医疗金鉴》登载的刘君主任及其机构 
 
 

慢性艾滋病早期中医药治疗保障生命论证

红津液饮料面世 或将能预防艾滋病

更多来源∶新浪商业登载
http://vic.sina.com.cn/news/27/2010/1231/26801.html


TOM新闻登载

http://post-social.news.tom.com/s/63000AD83310.html

中国青年网 健康频道

http://news.youth.cn/jk/201012/t20101231_1447239.htm

 环球时报-环球网

http://news.163.com/10/1231/15/6P8B7PTU00014JB6.html


 环球网

http://china.huanqiu.com/hot/2010-12/1390550.html

 

 

HIV can adapt to the new mutated virus vaccine: clinical trials next year http://www.sina.com.cn 2011 年 04 月 03 日 09:20 Sina Technology
 
The electronic laboratory WBC scan shows wall immunodeficiency virus (HIV-1) budding (green)
 
Bette Korber of the two friends died from AIDS, she devoted time to study the life of HIV vaccines
SAN FRANCISCO, April 3, according to foreign media reports, scientists say, one can fool deadly HIV vaccine may be human clinical trials next year. An international research group designed this "mosaic vaccine" able to adapt to variation in HIV.

HIV virus can mutate rapidly, which makes it no way the current drugs. Los Alamos National Laboratory in New Mexico, United States of Beit Korber is a member of the research group, she has 20 years of work on this project. She said: "The research on HIV was like entering an evolutionary fast track. If you only use a drug, the HIV virus can be easily evolved to avoid it. This is the treatment of the disease at the same time to use 3 or 4 drugs causes. "

HIV virus is mainly made up of protein, it can lead to AIDS, impairs the immune system, resulting in patients suffering from highly infectious diseases and cancer. In 2009, the disease caused 180 million deaths worldwide. Traditional HIV vaccine by stimulating the body's immune system, it can identify HIV in the special amino acids. The mosaic of the vaccine by a number of sorting through the computer artificial proteins. They suggest the immune system, so that it produces a variety of responses to HIV variants. Los Alamos National Laboratory, Korber and colleagues used to produce their own a huge database of stitching together these proteins, the database contains hundreds of thousands of pieces of information on HIV.

This mosaic vaccine would break the deadlock on 25 years of embarrassment, find a cure for AIDS. 7,500 people infected with HIV every day, every year 200 million people died of AIDS. All previous clinical trials of HIV vaccines are ended in failure. According to early results of computer simulation predicted that the vaccine will be mounted on HIV gene expression than the natural better. Part of this statement was confirmed last year, was published in "Nature Medicine" on the research results show that rats and monkeys make the vaccine mounted a very strong immune response. An international research group on the mosaic in 2012 would now like to conduct human clinical trials the vaccine, the study by the Bill & Melinda Gates Foundation and the National Institutes of Health funding.

Dr. Korber have several friends die of AIDS, she said, she desperately hoped that this new method can be successful. "I use the life of the vaccine research and development time. Now in animal studies, I believe this is a good way, is useful in human trials." If the safety of early stage trials have shown that the vaccine is safe for human use, scientists will be the second phase of the trial, the more people who tested the drug, evaluate its effectiveness. It is estimated that 73,000 Britons are living with HIV, of which 2.1 million people do not know the body contains the virus. (Takafumi)

 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:199    更新时间:2011-4-3    文章录入:nnb ]